| Business Name: | Teklacep Capital Management |
| Categorized In: | |
| Address: | 2 Liberty Square Floor 9, Boston, MA 02109 |
| Phone Number: | (617) 772-8500 |
| Contact Person: | Daniel Omstead, Chief Executive Officer |
| Website Address: | hqcm.com |
| NAICS Code: | 5239100 |
| SIC Code: | 6726 |
| Business Type: | B2B & B2C |
| Founding Year: | 1986 |
| Employee #: | 1 to 4 |
| Location Type: | Single Location |
| Annual Revenue ($): | $500.000.000 to $999.999.999 |
| Share This Business: | |
| Similar Businesses: |
Putnam Health Care Long/Short Fund Lp - Boston, MA 02109 Synchrony Venture Management - Boston, MA 02109 Putnam Voyager Fund Inc - Boston, MA 02109 Belair Capital Fund LLC - Boston, MA 02109 Apex Boston Group - Boston, MA 02109 Global Private Equity Iii-C Limited Partnership - Boston, MA 02109 Global Private Equity Iv-A Limited Partnership - Boston, MA 02109 Putnam High Income Convertible Bond Fund - Boston, MA 02109 Thunderstorm Capital - Boston, MA 02109 |
Teklacep Capital Management provides professional from its single location at the coordinates 42.3582,-71.05553.
The company offers BOTH variables under the SIC code 6726 and NAICS code 5239100, while making an annual revenue of $500.000.000 to $999.999.999 and hiring a total of 1 to 4 employees.
Founded in 1986, the company can now be visited at 2 Liberty Square Floor 9, Boston, Massachusetts 02109 or contacted through representative Daniel Omstead, Chief Executive Officer at (617) 772-8500.
For frequently asked questions and further inquiries about professional , get to know more about Teklacep Capital Management through its company website at hqcm.com. Engage with this business on its social media platforms through on Twitter and on Facebook.